Oragenics Inc.

AMEX: OGEN · Real-Time Price · USD
1.14
-0.05 (-4.20%)
At close: Aug 15, 2025, 3:59 PM
1.17
2.61%
After-hours: Aug 15, 2025, 07:37 PM EDT

Oragenics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-2.27M -2.22M -3.35M -2.46M -2.31M -2.45M -12.75M -2.01M -3.05M -2.84M -302.66K -3.92M -4.03M -6.04M -2.29M -4.38M -3.82M -5.22M
Depreciation & Amortization
578.58K 192.86K n/a n/a n/a n/a n/a 4.79K 11.3K 11.3K 13.07K 12.75K 10.38K 8.47K 6.42K 9.64K 12.45K 12.72K
Stock-Based Compensation
6.78K -68.76K 57.68K 330.8K 58.22K 69.34K 470.31K 402.93K 63.63K 79.97K -95.58K 468.55K 278.99K 90.25K 232.35K 100.77K 231.14K 1.12M
Other Working Capital
282.07K 159.64K 1.52M -243.39K 100.88K 11.06K 215.37K 444.87K 1.03M 644.87K -2.12M -263.05K -266.77K 164.21K 169.38K -906.68K 1.49M 120.31K
Other Non-Cash Items
-147 n/a n/a 181.4K n/a n/a 9.85M -22.44K 719.78K n/a -15.22M 2.72M 184.14K -10.96K -13.47M 527.13K -1.1M 1.51M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 476.04K n/a -719.78K n/a 15.22M -2.72M n/a n/a 13.47M n/a n/a n/a
Change in Working Capital
372.45K -19.19K 1.27M -19.58K 702.34K -682.76K 848.67K 124.61K 399.03K 644.87K -2.05M -339.54K 360.52K 310.69K 169.38K -906.68K 1.49M -243.97K
Operating Cash Flow
-1.31M -2.11M -2.02M -1.97M -1.54M -3.06M -1.1M -1.5M -2.58M -2.11M -2.43M -3.78M -3.38M -5.64M -1.88M -5.18M -2.08M -4.33M
Capital Expenditures
n/a n/a 3.00 n/a n/a n/a 5.00 n/a n/a n/a -3.44K -37.03K n/a -87.05K -19.75K -24.12K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a 63.71K n/a n/a n/a n/a n/a 12K n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -1M n/a n/a n/a -127.52K n/a n/a 12K -43.88K n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a -1M 63.72K n/a n/a -3.44K -37.03K n/a -75.05K -19.75K -24.12K n/a n/a
Debt Repayment
n/a 2.03M -262.83K -117.58K -126.84K -185.86K -180.72K -117.69K n/a -159.75K -157.28K -103.5K -122.17K n/a -779.01K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.64M n/a n/a -5.64M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.12M
Other Financial Acitivies
-132.96K n/a n/a n/a n/a n/a n/a n/a -107.89K n/a n/a n/a n/a -181.24K n/a -21.91K 152.26K 24.31M
Financial Cash Flow
-132.96K 4.67M -260.86K 3.77M 821.16K 1.65M -180.6K 732.12K -107.89K -159.75K -88K -103.5K -122.17K -181.24K -178.84K -21.91K 152.26K 23.19M
Net Cash Flow
-1.45M 2.56M -2.28M 1.8M -723.37K -1.41M -2.28M -707.18K -2.68M -2.27M -2.52M -3.92M -3.5M -5.89M -2.68M -4.63M -1.93M 18.86M
Free Cash Flow
-1.31M -2.11M -2.02M -1.97M -1.54M -3.06M -1.1M -1.5M -2.58M -2.11M -2.44M -3.81M -3.38M -5.72M -1.9M -5.2M -2.08M -4.33M